Legal Opinion
In re Nexium (Esomeprazole) Antitrust Litigation
District Court, D. Massachusetts
Decided November 14, 2013No. Civil Action No. 12-md-02409-WGYPublishedCited by 15 opinions
1Opinion of the Court
MEMORANDUM AND ORDER
YOUNG, District Judge.
I. INTRODUCTION
The named End-Payor plaintiffs seek class certification of a class comprised of individual consumers, third-party payors (“TPPs”), union plan sponsors, and insurance companies that purchased or provided reimbursements for Nexium in those states that permit such an action. See Corrected Con-sol. Am. Class Action Compl. & Demand Jury Trial (“End-Payors’ Compl.”) ¶¶ 14-23, ECF No. 114. The named End-Payors move for class certification under Federal Rules of Civil Procedure (“Rule”) 23(a), (b)(2), and (b)(3). End-Payor Pis.’ Mot. Class…
2Cases cited49 opinions
- Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
- Amchem Products, Inc. v. WindsorSupreme Court of the United States · 1997
- Wal-Mart Stores, Inc. v. DukesSupreme Court of the United States · 2011
- General Telephone Co. of Southwest v. FalconSupreme Court of the United States · 1982
- Richmond Newspapers, Inc. v. VirginiaSupreme Court of the United States · 1980
44 more not listed; retrieve them via the Exa API.
3Cited by15 opinions
- In re Rail Freight Fuel Surcharge Antitrust Litig.Court of Appeals for the D.C. Circuit · 2017
- In re Dial Complete Marketing & Sales Practices LitigationDistrict Court, D. New Hampshire · 2015
- Cromeans v. Morgan Keegan & Co.District Court, W.D. Missouri · 2014
- In re Restasis (Cyclosporine Ophthalmic Emulsion) Antitrust Litig.District Court, E.D. New York · 2018
- In re Nexium (Esomeprazole) Antitrust LitigationDistrict Court, D. Massachusetts · 2015
10 more not listed; retrieve them via the Exa API.